Reuters logo
BRIEF-Newron announces encouraging preliminary results of its phase IIa study with Evenamide in patients with schizophrenia
January 3, 2017 / 4:37 PM / in a year

BRIEF-Newron announces encouraging preliminary results of its phase IIa study with Evenamide in patients with schizophrenia

Jan 3 (Reuters) - Newron Pharmaceuticals Spa

* Newron announces encouraging preliminary results of its phase IIa study with Evenamide in patients with schizophrenia Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below